Washington University
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 3, 2025), Washington University reported 3 stock positions worth $178.5 million. Its top holding was Nu Holdings Ltd./Cayman Isl-A (NU) at 94.8% of the portfolio, followed by Maze Therapeutics (MAZE, 3.1%) and Moderna (MRNA, 2.2%). Compared with Q2 2025, it opened 1 new position, sold out of 2 and added to 1. The biggest buy was Nu Holdings Ltd./Cayman Isl-A (NU, shares +2%) and the biggest sale an exit from Samsara Class A (IOT).
- Most Recent 13F
- Q2 2026
- Location
- ST LOUIS, MO
- CIK
- 0000903603
- Portfolio Value
- $178.5M (Q3 2025)
- SEC Filing
- 0000903603-25-000007 ↗ filed Nov 3, 2025
Holdings Value
Holdings 3 stocks · $178.5M
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $264.8M | NU, CBRS, RBRK |
| Q1 2026 | 2 | $160.2M | NU, MAZE |
| Q4 2025 | 5 | $197.8M | NU, MAZE, MRNA, RBRK, FIG |
| Q3 2025 | 3 | $178.5M | NU, MAZE, MRNA |
| Q2 2025 | 4 | $121.4M | NU, IOT, MRNA, PONY |
| Q1 2025 | 2 | $110.8M | NU, MRNA |
| Q4 2024 | 3 | $117.5M | NU, MRNA, ROAD |
| Q3 2024 | 4 | $154.2M | NU, MRNA, UTI, CART |
| Q2 2024 | 3 | $219.7M | NU, MRNA, UTI |
| Q1 2024 | 5 | $270.4M | NU, UTI, CPNG, MRNA, U |